(Q45372939)

13 December 2017

title

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients (English)

1 reference

13 December 2017

11

Gerd Fätkenheuer

1 reference

13 December 2017

10

Thomas Lengauer

1 reference

13 December 2017

13

Dieter Häussinger

1 reference

13 December 2017

5

Rolf Kaiser

1 reference

13 December 2017

4

Bastian Beggel

1 reference

13 December 2017

2

Mark Oette

1 reference

13 December 2017

6

Melanie Balduin

1 reference

13 December 2017

Stefan Reuter

1

1 reference

13 December 2017

Frank Clemens Wilhelm

3

1 reference

13 December 2017

Finja Schweitzer

7

1 reference

13 December 2017

Jens Verheyen

8

1 reference

13 December 2017

Ortwin Adams

9

1 reference

13 December 2017

Herbert Pfister

12

1 reference

13 December 2017

language of work or name

1 reference

19 September 2010

1 reference

Medical Microbiology and Immunology

13 December 2017

published in

1 reference

13 December 2017

volume

200

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

39-49

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-010-0172-z

13 December 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Influence of viral hepatitis on HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Lack of 'occult' hepatitis B virus infection in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Changes in hepatitis B virus DNA levels with acute HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Low Prevalence of Ongoing Hepatitis B Viremia in HIV-Positive Individuals with Isolated Antibody to Hepatitis B Core Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

HCV Coinfection Associated with Slower Disease Progression in HIV-Infected Former Plasma Donors Naïve to ART

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Evolution of Hepatitis B Serological Markers in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-010-0172-Z

Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen

21 January 2018

1 reference

12 December 2020

Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters

1 reference

12 December 2020

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

1 reference

12 December 2020

Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany

1 reference

12 December 2020

A 2010 update on occult hepatitis B infection

1 reference

12 December 2020

Occult hepatitis B in HIV-HCV coinfected patients

1 reference

12 December 2020

Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction.

1 reference

12 December 2020

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

1 reference

12 December 2020

Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus

1 reference

12 December 2020

Trends of prevalence of primary HIV drug resistance in Germany

1 reference

12 December 2020

Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

10.1007/S00430-010-0172-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1045642854

0 references

1 reference